POLYMORPHISMS OF INSULIN RECEPTOR SUBSTRATE 1 AS A RISK FACTOR FOR TYPE 2 DIABETES MELLITUS, OBESITY AND CHRONIC PANCREATITIS AMONG POPULATION OF TERNOPIL REGION
Keywords:type 2 diabetes mellitus, obesity, chronic pancreatitis, insulin receptor substrate 1, genes polymorphism
Background. The course of type 2 diabetes mellitus (T2DM), obesity and chronic pancreatitis (CP) in most cases is not isolated, so it requires broadening the knowledge about the pathogenetic links at their combined course. Despite significant advances in genome research, most of the genetic factors that cause development of T2DM are still unclear.
Objective. The aim of the study was to establish the prevalence of IRS1 gene polymorphism in the patients with T2DM as well as obesity and CP.
Methods. The study involved 34 patients with T2DM who were hospitalized in the endocrinology department of Ternopil University Hospital in 2019-2020 and 10 apparently healthy patients. Analysis of IRS1 gene polymorphism (SNP in the promoter region - rs2943640; gene localization 2q36.3) was performed on the basis of polymerase chain reaction data using specific primers.
Results. It was found that the frequencies of the genotype responsible for C/A polymorphism of IRS1 gene in T2DM, T2DM with obesity and in the combined course of T2DM with obesity and CP did not deviate significantly from the Hardy-Weinberg equilibrium (p>0.05). The patients with combined course of T2DM, obesity and chronic pancreatitis experienced a probable influence of genotypes C/C and C/A of IRS1 gene on the development of the studied comorbidity (p<0.05), which is confirmed by a probable difference in the dominant model of IRS1 gene inheritance only when T2DM was combined with obesity and CP compared to the control group (p<0.001).
Conclusions. The presence of the C allele in both homozygous and heterozygous states may increase the risk of T2DM comorbidity, obesity and CP in the population of Ternopil region.
Roy S, Sherman A, Monari-Sparks MG, Schweiker O, Jain N, Etty Sims E, et al. Association of comorbid and metabolic factors with optimal control of type 2 diabetes mellitus. N Am J Med Sci. 2016; 8(1):31-9.
Jani BD, Hanlon P, Nicholl BI, McQueenie R, Gallacher KI, Lee D, et al. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank. BMC Med. 2019; 17(1):74.
Nowakowska M, Zghebi SS, Ashcroft DM, Buchan I, Chew-Graham C, Holt T, et al.The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Medicine. 2019;17:145.
Teljeur C, Smith SM, Paul G, Kelly A, O'Dowd T. Multimorbidity in a cohort of patients with type 2 diabetes. Eur J Gen Pract. 2013;19 (1):17-22.
Lonso-Morán E, Orueta JF, Esteban JIF. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health. 2014;14: 1059.
Luijks H, Schermer T, Bor H, Weel C, Lagro-Janssen T, Biermans M, et al. Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study BMC Med. 2012; 10 (1): 128.
Struijs JN, Baan CA, Schellevis FG, Westert GP, van den Bos GA. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res. 2006; 6: 84.
Li X, Guo X, Ji H, Niu J, Gao P. Relationships between metabolic comorbidities and occurrence, severity, and outcomes in patients with acute pancreatitis: A narrative review. Biomed Res Int. 2019 Oct 7;2019:2645926.
Samsonova NG, Zvenigorod LA. Pancreas and metabolic syndrome. Experimental and clinical gastroenterology. 2011; 11: 68-72.
American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes–2019. Diabetes care. 2019 Jan 1;42(Supplement 1):S34-45.
Antonyshyn IV, MI Marushchak, OV Denefil. [State of lipid peroxidation in experimental diet-induced alimentary obesity]. Medical Chemistry. 2014; 16 (3): 61-5. (In Ukrainian)
Hevko U, Kozak K, Krynytska I, Marushchak M. Diagnostic value of a complete blood count in type 2 diabetes mellitus and comorbidities. Balkan Medical Union. 2020; 55(4): 601-7.
DOI: https://doi.org/10.31688/ABMU.2020. 55.4.06
Plengvidhya N, Chanprasert C, Chongjaroen N, et al. Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population. BMC Med Genet. 2018; 19:93.
Musiienko VA, Marushchak MI. [Type 2 diabetes and thyroid disease: finding common mechanisms]. Vìsn. med. bìol. dosl.. 2020; 1: 74-82. (In Ukrainian).
DOI: https://doi.org/10.11603/bmbr.2706-6290. 2020.1.11006
Yousef AA, Behiry EG, Allah WMA, Hussien AM, Abdelmoneam AA, Imam MH, Hikal DM. IRS-1 genetic polymorphism (r.2963G>A) in type 2 diabetes mellitus patients associated with insulin resistance. Appl Clin Genet. 2018 Sep 28;11:99-106.
American Diabetes Association. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes—2019. Diabetes care. 2019 Jan 1;42(Supplement 1):S103-23.
Conwell DL, Lee LS, Yadav D, Longnecker DS, Miller FH, Mortele KJ, et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43(8):1143-62.
DOI: https://doi.org/10.1097/MPA. 0000000000000237
Order of the Ministry of Health of Ukraine № 638 dated 10.09.2014 https://zakononline.com.ua/documents/show/35092___35092.
Body Mass Index: Considerations for Practitioners / https://www.cdc.gov/obesity/downloads/bmiforpactitioners.pdf.
Chen J, Meng Y, Zhou J, Zhuo M, Ling F, Zhang Yu,et al. Identifying candidate genes for type 2 diabetes mellitus and obesity through gene expression profiling in multiple tissues or cells. J Diab Res. 2013:9.
Langenberg C, Sharp SJ, Franks PW, et al. Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study. PLoS Med. 2014 May;11 (5):e1001647.
DOI: https://doi.org/10.1371/journal.pmed. 1001647
Liu J, Rutten-Jacobs L, Liu M, Markus HS, Traylor M. Causal impact of type 2 diabetes mellitus on cerebral small vessel disease: A mendelian randomization analysis. Stroke. 2018 Jun;49 (6):1325-31.
DOI: https://doi.org/10.1161/STROKEAHA.117. 020536
Loos RJ, Hagberg JM, Pérusse L, et al. Advances in exercise, fitness, and performance genomics in 2014. Med Sci Sports Exerc. 2015 Jun;47 (6):1105-12.
Karaderi T, Drong AW, Lindgren CM. Insights into the Genetic Susceptibility to Type 2 Diabetes from Genome-Wide Association Studies of Obesity-Related Traits. Curr Diab Rep. 2015;15 (10):83.
How to Cite
Copyright (c) 2021 International Journal of Medicine and Medical Research
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).